ANO10

Chr 3AR

anoctamin 10

Also known as: SCAR10, TMEM16K

The protein encoded by ANO10 is a transmembrane protein belonging to the anoctamin family of calcium-activated chloride channels that inhibits the activity of ANO1, though it does not itself exhibit calcium-activated chloride channel activity. Mutations cause autosomal recessive spinocerebellar ataxia-10 through a predicted gain-of-function mechanism. The inheritance pattern is autosomal recessive.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
MultiplemechanismARLOEUF 1.131 OMIM phenotype
Clinical SummaryANO10
🧬
Gene-Disease Validity (ClinGen)
autosomal recessive spinocerebellar ataxia 10 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
12 unique Pathogenic / Likely Pathogenic· 50 VUS of 100 total submissions
📖
GeneReview available — ANO10
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.13LOEUF
pLI 0.000
Z-score 0.99
OE 0.81 (0.591.13)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.32Z-score
OE missense 0.95 (0.871.04)
327 obs / 343.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.81 (0.591.13)
00.351.4
Missense OE0.95 (0.871.04)
00.61.4
Synonymous OE1.11
01.21.6
LoF obs/exp: 25 / 30.9Missense obs/exp: 327 / 343.5Syn Z: -0.95
DN
0.6746th %ile
GOF
0.76top 25%
LOF
0.2678th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic5
VUS50
Likely Benign22
7
Pathogenic
5
Likely Pathogenic
50
VUS
22
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
0
3
0
7
Likely Pathogenic
5
0
0
0
5
VUS
0
49
1
0
50
Likely Benign
0
0
6
16
22
Benign
0
0
0
0
0
Total949101684

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ANO10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →